Of importance, therapeutic targeting of HMGB1 in AD might be immature at present since it is implicated at multiple levels in the regulation of immune response, and the precise underlying mechanism of its involvement in AD has not been completely understood. Here, HMGB1 is linked to Alzheimer disease.